Followers | 5 |
Posts | 973 |
Boards Moderated | 0 |
Alias Born | 03/03/2011 |
Sunday, November 13, 2011 12:55:41 PM
http://www.drreddys.com/investors/pdf/q2-fy12-earnings-call-transcript.pdf
Surajit Pal I have just one question. Going by the company’s pretty fantastic performance on protein based products, though there is no news from company’s side. Is there any kind of activities on Lovenox filing? Because it is a big product and very few competition is there.
Kedar Upadhye Surajit, which molecule you are referring to?
Surajit Pal Enoxaparin
Umang Vohra We are not disclosing that, Surajit. Sorry, we cannot not disclose at this pointin time.
Surajit Pal But will it be right to think that there’s some activities are on around from the
company’s side going by your efficiency in fondaparinux?
G. V. Prasad They are not related. Fondaparinux is a synthetic molecule and Lovenox is semi synthetic. That’s not a conclusion you could draw.
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM